3- (2-Hydroxyethyl) thio withaferin A

3- (2-Hydroxyethyl) thio withaferin A is a Withaferin A derivative. Withaferin A, a steroidal lactone, inhibits NF-kB activation and targets vimentin, with potent antiinflammatory and anticancer activities. Withaferin A is an inhibitor of endothelial protein C receptor (EPCR) shedding[1][2][3].

Product Specifications

UNSPSC

12352005

Target

NF-κB

Type

Natural Products

Related Pathways

NF-κB

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/3-2-hydroxyethyl-thio-withaferin-a.html

Solubility

10 mM in DMSO

Smiles

C[C@H](C1OC(C(CO)=C(C)C1)=O)C2CCC3C4C[C@@H]5[C@]([C@@]6(C)C4CC[C@@]32C)(O5)[C@@H](O)[C@@H](SCCO)CC6=O

Molecular Formula

C30H44O7S

Molecular Weight

548.73

References & Citations

[1]Kaileh M, et al. Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem. 2007 Feb 16;282 (7) :4253-64. Epub 2006 Dec 6.|[2]Bargagna-Mohan P, et al. The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin. Chem Biol. 2007 Jun;14 (6) :623-34.|[3]Kakar SS, et al. Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells. Oncotarget. 2017 Aug 10;8 (43) :74494-74505.